By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nymox Pharmaceutical Corporation 

9900 Cavendish Boulevard

St.-Laurent  Quebec  H4M 2V2  Canada
Phone: 800-936-9669 Fax: 514-332-2227


SEARCH JOBS


Industry
Pharmaceutical






Company News
Sexual Function Improves In First-Line Patients Given Fexapotide Treatment In Nymox (NYMX) U.S. BPH Long-Term Clinical Trials 5/31/2017 8:39:53 AM
Nymox (NYMX) Files For Approval Of First In Class Prostate Drug In Europe: Teleconference At 4:30 EDT 5/10/2017 12:31:25 PM
Nymox (NYMX) Files For Approval Of First In Class Prostate Drug In Europe: Company To Hold Teleconference Wednesday May 10 At 4:30 EDT 5/8/2017 10:45:21 AM
Nymox (NYMX) Files For Marketing Approval For Fexapotide Triflutate In Europe 5/3/2017 10:10:40 AM
Nymox (NYMX) Provides Update On Fexapotide Development 3/29/2017 9:56:44 AM
Nymox (NYMX) Reports Additional Positive Results From Completed Fexapotide BPH Phase III Studies Showing Significant Early Response And First-Line Efficacy 11/30/2016 8:07:05 AM
Nymox (NYMX) Reports Additional Positive Results From Completed Fexapotide BPH Phase III Studies Showing Significant Early Response And First-Line Efficacy 11/29/2016 7:51:05 AM
Nymox (NYMX)'s New Phase III Long-Term U.S. Results For Prostate Enlargement Drug Fexapotide Show 8/29/2016 11:45:29 AM
Taking a Closer Look at Nymox (NYMX)'s 'Overinflated' Prostate Drug Hype 8/29/2016 6:58:51 AM
Nymox Pharmaceutical (NYMX) Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results: Major Reduction In Incidence Of Surgery 8/24/2016 11:19:36 AM
12345678910...
//-->